BSE filing, NSE: MEDICAPQ. Summary written from the filing by ALFA Finder's alert engine.
Medi Caps Ltd: key numbers
- Share price
- ₹24.84
- Market cap
- ₹30.98 Cr
- Revenue (annual)
- ₹12.45 Cr
- Net profit (annual)
- ₹-3.04 Cr
- P/E (TTM)
- -17.4×Sector 46.1×
- Promoter holding
- 51.44%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medi Caps Ltd
All →Medi Caps Board Meeting Date
Medi-Caps Ltd intimated its Board meeting is scheduled for 04 November 2026 to consider Q1 and H1 FY27 financial results. No decisions have been taken yet.
Medi Caps Other Announcement
The company submitted its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the quarter ended September 30, 2026.
Medi-caps Management Change
Medi-Caps Limited has re-appointed Alok K Garg as Executive Director and appointed Saloni Garg as an additional Executive Director for a 36-month term.
Medi Caps Annual General Meeting
Medi-Caps Limited held its 43rd Annual General Meeting on September 22, 2026. The meeting proceedings covered financial adoption and director appointments.
Medi Caps Other Announcement
Medi-Caps Limited is notifying shareholders without registered email addresses about the 43rd AGM and Annual Report availability. The documents are accessible via the provided web links.
Medi Caps Annual Report
Medi-Caps Limited has submitted its Integrated Annual Report for the financial year 2025-26. The 43rd Annual General Meeting is scheduled for September 22, 2026.
Other other announcement announcements
All →ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.